111 results on '"Gennaro, Elena"'
Search Results
2. qPCR Applications for the Determination of the Biological Age
3. Supplementary Figure 2 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
4. Supplementary Figure Legends 1-2 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
5. Supplementary Figure 1 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
6. Supplementary Figure Legends 1-2 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
7. Supplementary Figure 2 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
8. Supplementary Figure 1 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
9. New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
10. Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection
11. Surgical Treatment Following Failed Medical Treatment of an Interstitial Pregnancy
12. Abstract 1353: Immunomodulatory effects of valproic acid in combination with cisplatin and cetuximab in head and neck squamous cell carcinoma
13. Epilepsy Course and Developmental Trajectories in STXBP1-DEE
14. Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
15. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
16. Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
17. A new CHD2 variant: not only severe epilepsy—a case report
18. Placenta accreta in the first trimester: A case report
19. Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer
20. Abstract 1158: The HDAC inhibitor domatinostat (4SC-202) sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
21. New Perspective for an Old Antidiabetic Drug: Metformin as Anticancer Agent
22. Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations
23. Histone Deacetylase Inhibitors in Cancer Therapy
24. Locally Advanced Rectal Cancer: Combined Chemotherapy During Preoperative Radiation Therapy
25. HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
26. Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants
27. Dual diagnosis in a child with familial SCN8A-related encephalopathy complicated by a 1p13.2 deletion involving NRAS gene
28. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
29. Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
30. Abstract 5223: Valproic acid, by preventing cisplatin/cetuximab-induced EGFR nuclear translocation and increasing cisplatin uptake, potentiates the antitumor effect of the combination treatment in head and neck squamous cell carcinomas
31. A further contribution to the delineation of epileptic phenotype in PACS2-related syndrome
32. Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant
33. Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients withRAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol
34. Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake
35. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
36. Abstract 5268: Outcome prediction of metastatic colorectal cancer patients undergoing liver resection by analyzing serum metabolomics
37. Abstract 5268: Outcome prediction of metastatic colorectal cancer patients undergoing liver resection by analyzing serum metabolomics
38. A novel mutation in KCNQ3 ‐related benign familial neonatal epilepsy: electroclinical features and neurodevelopmental outcome
39. Chewing induced reflex seizures (“eating epilepsy”) and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases
40. FXS-Like Phenotype in Two Unrelated Patients Carrying a Methylated Premutation of the FMR1 Gene
41. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy
42. A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges
43. Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
44. CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation
45. Synthesis and Evaluation of the Antitumor Properties of a Small Collection of PtIIComplexes with 7-Deazaadenosine as Scaffold
46. Abstract 4058: Preclinical and phase-2 clinical study of valproic acid administered in combination with cisplatin and cetuximab in recurrent/metastatic head and neck cancer
47. Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents
48. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy
49. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients
50. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.